ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,051Medicare Part D Prescriptions Filled, Including Refills

Rank: 571 out of 2061

$672K Total Retail Price of All Prescriptions

Rank: 390 out of 2061

428 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
9% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 428 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 428 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 8,321 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
AMLODIPINE BESYLATE 436 413 1 4
SIMVASTATIN 436 404 1 1
LISINOPRIL 393 362 3 2
LEVOTHYROXINE SODIUM 381 361 4 3
ATORVASTATIN CALCIUM 342 336 5 8
OMEPRAZOLE 319 301 6 5
FUROSEMIDE 224 215 7 6
AMLODIPINE BESYLATE-BENAZEPRIL 221 206 8 79
EVISTA 173 173 9 150
ATENOLOL 171 148 10 13
ZOLPIDEM TARTRATE 163 148 11 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 157 143 12 27
TAMSULOSIN HCL 154 154 13 30
LOSARTAN POTASSIUM 142 128 14 17
HYDROCHLOROTHIAZIDE 135 121 15 12
CITALOPRAM HBR 119 109 16 20
CARVEDILOL 113 101 17 22
ALLOPURINOL 98 86 18 28
HYDROCODONE-ACETAMINOPHEN 96 89 S3 19 10
MELOXICAM 88 75 20 44
CRESTOR 87 66 21 31
VENLAFAXINE HCL ER 86 71 22 109
CYMBALTA 80 80 23 59
NABUMETONE 78 74 24 196
EXELON 77 77 25 94
DOXAZOSIN MESYLATE 77 70 25 81
FLUOXETINE HCL 75 63 27 73
MIRTAZAPINE 74 61 28 46
METFORMIN HCL 73 63 29 9
NAMENDA 71 71 30 37
PREDNISONE 70 42 31 32
METOPROLOL TARTRATE 68 68 32 7
ROPINIROLE HCL 65 54 33 92
POTASSIUM CHLORIDE 64 64 34 16
TRAMADOL HCL-ACETAMINOPHEN 63 56 35 194
JANUVIA 58 52 36 51
METOPROLOL SUCCINATE 57 53 37 19
PROAIR HFA 57 48 37 40
ADVAIR DISKUS 56 44 39 57
CLOPIDOGREL 55 55 40 29
ACTOS 55 55 40 140
OXYBUTYNIN CHLORIDE ER 54 54 42 80
BENICAR 53 53 43 175
WARFARIN SODIUM 51 47 44 11
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 25, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.